AARA remains at the forefront of rheumatologic care, by participating in clinical trials of new rheumatologic drugs through the enrollment and supervision of patients who qualify and who may be in need of other potentially effective therapies. In a clinical new drug trial, trial medications are supplied at no cost to participating patients. Clinical trials may offer benefit to patients who have not responded to conventionally available treatments. Our research wing, Arizona Arthritis Research, PLC, (AAR) keeps us involved in the valuable process of new drug development.

As long as people continue to suffer from the damage of immunologic illness and musculoskeletal disorders, medical scientists and pharmaceutical and device companies will forge ahead for the next better treatment. Only real people with these disorders can move this science ahead for themselves and others who will suffer these disorders in the future. We encourage our patients whenever appropriate to consider contributing to medical science through enrollment in FDA supervised clinical trials.

....................................................................................................

Currently Enrolling Trials at AARA / AARR:

Rheumatoid Arthritis

 

Rheumatoid Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Gout and Osteoarthritis are therapeutic areas wherein AARA/AARR are continuously active. At times, we perform studies of treatments for other inflammatory diseases. If you or a friend or loved one are considering participation in the development of new advances for these disorders, please contact our staff.

....................................................................................................

Contact our research staff about study involvement:
(480) 443-8400 ext. 151/150
Fax: (480) 443-7420
Fen@azarthritis.com